Objective Capital Management, LLC Pfizer Inc Transaction History

Objective Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $144 - $167	-4 Reduced 0.07%	6,028 $221,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $6,420 - $8,358	-163 Reduced 2.63%	6,032 $246,000
Q4 2022 Feb 27, 2023	BUY	$41.75 - $54.5 $44,296 - $57,824	1,061 Added 20.67%	6,195 $317,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $10,021 - $12,233	229 Added 4.67%	5,134 $225,000
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $8,421 - $9,985	-181 Reduced 3.56%	4,905 $257,000
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $6,725 - $8,333	-147 Reduced 2.81%	5,086 $263,000
Q4 2021 Apr 20, 2022	BUY	$41.32 - $61.25 $216,227 - $320,521	5,233 New	5,233 $309,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Objective Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Objective Capital Management, LLC with notifications on news.